FAAH and colitis: In addition, other studies using the TNBS model of colitis reported protective effects against inflammatory damage in mice lacking FAAH.71 Collectively, the results highlight the role for CB1Rs and CB2Rs in experimental models of colitis and provide strong evidence for the therapeutic value of cannabinoid-based therapeutics for the treatment of inflammatory bowel disease.